We previously carried out a genome-wide siRNA screen in isogenic breast MCF10A cells with and without E-cadherin expression and observed that GPCRs and cytoskeletal proteins frequently displayed an SL relationship with E-cadherin [
7]. To elucidate the mechanisms underpinning synthetic lethality in E-cadherin-deficient cells, we have now extended our analysis of the siRNA screen data to include genes with the reverse effect to synthetic lethality, that is, genes whose siRNAs reduced the viability of MCF10A cells more than MCF10A
-CDH1−/− cells. We have termed these genes ‘reverse synthetic lethal’ (RSL). We hypothesise that RSL proteins have direct or indirect interactions with E-cadherin, but
CDH1−/− cells have compensated for the loss of this interaction, making them less sensitive to knockdown of RSL proteins (relative to wild-type cells). This adaption is most likely to have occurred through the activation of one or more proteins with overlapping function (i.e., functional redundancy). In contrast to these RSL proteins, we hypothesise that MCF10A
-CDH1−/− cells have been unable to fully compensate for the loss of the interaction between E-cadherin and any given SL protein, exposing a vulnerability (summarised in Fig.
1a). Although RSL proteins may not represent useful drug targets on their own, compounds which also inhibit the functional homologue may prove to be SL. Regardless, the identity of RSL proteins provides a fuller understanding of the impact of E-cadherin loss on epithelial cells. 1648 genes met our RSL threshold of a MCF10A
-CDH1−/−/MCF10A viability ratio of ≥ 1.3. Using the DAVID Functional Annotation Clustering tool v6.8 [
15], the most enriched functional cluster identified amongst RSL genes was a group of terms associated with phosphatases (enrichment score = 14.88; Table
1). Of 239 phosphatases in the Human Dephosphorylation Database, 224 were included in our siRNA screen. A density distribution of the MCF10A
-CDH1−/−/MCF10A viability ratios for these 224 phosphatases produced a single peak with the highest density occurring at a viability ratio of 1.34 (Fig.
1b). This distribution was shifted significantly (
p < 2.2 × 10
−16) in the RSL direction compared to the distribution of all 18,120 genes in the siRNA screen which displayed a single peak centered around a MCF10A
-CDH1−/−/MCF10A ratio of 1.00. In contrast, the overall density distribution of 496 protein kinases in the siRNA screen showed a small but highly significant shift (
p < 2.2 × 10
−16) towards synthetic lethality with the peak of the density distribution at 0.95 (Fig.
1c). The contrasting cell viability distribution of kinase and phosphatase siRNAs is likely to be related to the greater functional promiscuity of phosphatases [
16]. Ion channels were also highly enriched in the gene set analysis of RSL genes (enrichment score = 10.93; Table
1). Consistent with this observation, the MCF10A
-CDH1−/−/MCF10A density distribution of 161 voltage-gated ion channels in the siRNA screen was significantly right-shifted from the overall distribution of all 18,120 genes with a peak at 1.14 (
p < 2.2 × 10
−16; Fig.
1d). In contrast, the distribution of 370 solute carrier genes was not significantly different to the distribution of all 18,120 genes (
p = 0.45; Fig.
1e). The RSL phenotype of the ion channels was observed in most voltage-gated ion channel subgroups with the exception of small families of gap junction (
n = 20), bestrophin (
n = 4) and leucine-rich repeat channel (
n = 5) proteins which showed a contrasting trend towards a SL phenotype (Fig.
1f). Terms associated with ribosomes, splicing and proteasomes were also enriched in the RSL gene set analysis (Table
1). Cytoplasmic ribosomal proteins (
n = 78) and spliceosome proteins (
n = 132) showed a corresponding significant RSL shift in the MCF10A
-CDH1−/−/MCF10A density distributions (Fig.
1g, h), as did ubiquitin-specific peptidases (
n = 55), E2 ubiquitin conjugating enzymes (
n = 36), HECT E3 ubiquitin ligases (
n = 25) and proteasome complex proteins (
n = 43) (Fig.
1i, j, k, m). In contrast, the RING E3 ubiquitin ligases (
n = 299) were not RSL, but instead featured a large SL shoulder in the MCF10A
-CDH1−/−/MCF10A ratios centered at approximately 0.8 (
p < 2.2 × 10
−16) (Fig.
1l). Surprisingly, GPCR signalling terms were highly enriched amongst the RSL gene functions (enrichment score = 14.33; Table
1) just as they were in the SL gene functions [
7]. Of the 1409 GPCRs identified by the Human Gene Nomenclature Committee, 721 were represented in the siRNA screen, including 245 non-sensory, 86 orphan, 363 olfactory GPCRs and 27 taste GPCRs. Consistent with the gene ontology analyses, the MCF10A
-CDH1−/−/MCF10A density distributions for the 245 non-sensory GPCRs had a bimodal distribution, with peaks at viability ratios of 0.82 and 1.37 (
p = 1.0 × 10
−12; Fig.
2a). The left peak contained the SL GPCRs identified previously and the right peak comprised the set of RSL GPCRs. A similar bimodal distribution was also observed for the 86 orphan GPCRs (peaks at 0.82 and 1.39; Fig.
2b). In contrast, the viability ratio distribution of the taste and olfactory GPCRs (which have negligible expression in breast cells) predictably presented as single peaks centered at viability ratios of 0.97 (Fig.
2c) and 1.07, respectively. The density distributions for a set of 35 guanine nucleotide binding protein (G-protein) genes showed a single major peak that was shifted in the SL direction (max = 0.92,
p = 0.05; Fig.
2d). Together, the above results demonstrate that whole classes of membrane receptors, channels and protein-modifying enzymes are influenced by E-cadherin loss.